In:
Journal of Interventional Cardiology, Hindawi Limited, Vol. 2020 ( 2020-07-18), p. 1-11
Abstract:
Objective . To compare major clinical outcomes after successful percutaneous coronary intervention (PCI) with first-generation (1G) drug-eluting stents (DES) and second-generation (2G) DES in patients with acute myocardial infarction (AMI) and prediabetes. Background . Patients with prediabetes are associated with an increased incidence of coronary artery disease. The relative superiority of 1G- and 2G-DES in these patients is not well established. Methods . A total of 4997 patients with AMI and prediabetes were divided into two groups: the 1D-DES group ( n = 726) and the 2G-DES group ( n = 4271). The primary outcomes were the patient-oriented composite outcomes (POCOs) defined as all-cause death, recurrent myocardial infarction (Re-MI), and any disease revascularization at 2-year follow-up. The secondary outcome was probable or definite stent thrombosis (ST). Results . After propensity score-matching (PSM) analysis, two PSM groups (698 pairs, n = 1396, C-statistics = 0.725) were generated. The cumulative incidence rates of POCOs (hazard ratio (HR): 1.467; 95% confidence interval (CI): 1.068–2.015; p = 0.018 ), any disease revascularization (HR: 2.259; 95% CI: 1.397–3.654; p = 0.001 ), and ST (HR: 4.361; 95% CI: 1.243–15.30; p = 0.021 ) in the 1G-DES group were significantly higher than those in the 2G-DES group. However, the cumulative incidence rates of all-cause death, cardiac death, and Re-MI were similar between the two groups. Conclusions . In patients with AMI and prediabetes, 2G-DES implantation was more efficacious than 1G-DES implantation over a 2-year follow-up period. However, further studies are needed to confirm these results.
Type of Medium:
Online Resource
ISSN:
0896-4327
,
1540-8183
DOI:
10.1155/2020/1710439
Language:
English
Publisher:
Hindawi Limited
Publication Date:
2020
detail.hit.zdb_id:
2103585-4
Permalink
